373 related articles for article (PubMed ID: 20937370)
21. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
22. Alginate microparticles prepared by spray-coagulation method: preparation, drug loading and release characterization.
Tu J; Bolla S; Barr J; Miedema J; Li X; Jasti B
Int J Pharm; 2005 Oct; 303(1-2):171-81. PubMed ID: 16129575
[TBL] [Abstract][Full Text] [Related]
23. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
24. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
25. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Ahuja N; Katare OP; Singh B
Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
[TBL] [Abstract][Full Text] [Related]
26. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
[TBL] [Abstract][Full Text] [Related]
27. Development and physicochemical evaluation of pharmacosomes of diclofenac.
Semalty A; Semalty M; Singh D; Rawat MS
Acta Pharm; 2009 Sep; 59(3):335-44. PubMed ID: 19819829
[TBL] [Abstract][Full Text] [Related]
28. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
[TBL] [Abstract][Full Text] [Related]
29. Preparation and pharmaceutical evaluation of new sustained-release capsule including starch-sponge matrix (SSM).
Shibata N; Nishumura A; Naruhashi K; Nakao Y; Miura R
Biomed Pharmacother; 2010 May; 64(5):352-8. PubMed ID: 20006463
[TBL] [Abstract][Full Text] [Related]
30. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
31. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
32. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
[TBL] [Abstract][Full Text] [Related]
33. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin.
Uchiyama H; Tozuka Y; Imono M; Takeuchi H
Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634
[TBL] [Abstract][Full Text] [Related]
34. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
Mallick S; Sahu A; Pal K
Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
[TBL] [Abstract][Full Text] [Related]
35. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
Kumar S; Gupta SK
Arch Pharm Res; 2014 Mar; 37(3):340-51. PubMed ID: 23674128
[TBL] [Abstract][Full Text] [Related]
36. Use of SBA-15 for furosemide oral delivery enhancement.
Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
[TBL] [Abstract][Full Text] [Related]
37. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
38. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
Mehanna MM; Motawaa AM; Samaha MW
Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
[TBL] [Abstract][Full Text] [Related]
39. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
Papadimitriou S; Bikiaris D
Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
[TBL] [Abstract][Full Text] [Related]
40. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
